J K Tyres

ICICI Direct is bullish on J K Tyres and has set a price target of Rs 285 on the stock. "With net debt levels appearing to have hit a peak and likely to ease downwards, we believe the major market concern is likely to be alleviated. Improvement in return ratios is also a major positive. Hence, we do not believe the lowly valuations are justified. We recommend BUY with a target price of Rs 285," the research firm has stated.

Aurobindo Pharma

Prabhudas Lilladher is bullish on Aurobindo Pharma and has set a price target of Rs 749 on the stock.
"The stock with an ROE and ROCE of 43.3% and 21.4 in FY14 and expected ROE and ROCE of 41.0% and 24.3% in FY15 is one of the cheapest stocks in the health care universe. We continue to maintain a ‘Buy' and raise the TP to Rs 749", says Prabhudas Lilladher research report.

Dishman Pharma

Angel Broking has a buy call on Dishman Pharma with a price target of Rs 123. "At current levels, Dishman is trading at 4.7x and 4.0x FY2015E and FY2016E earnings, respectively. Hence, we maintain a buy on the stock with a price target of Rs 123," the firm has stated.

Strong order book to help growth

Maximus Securities has a buy call on KEC International. The brokerage firm has set a price target of Rs 160 on the stock. "Considering KEC International's strong order book, revenue visibility, improving margins, and formation of a stable government at the centre, we come up with a buy recommendation on KEC with a target price of Rs 160 per share which is 13.77x its FY16E," the firm has said in its research report.

Emkay puts a buy call on KEC

Emkay Global has set a price target of Rs 150 on KSK Energy. "Maintain Buy, as we remain positive from 1-1.5 years view and expect Mahanadi to earn reasonable RoE. However, pain in the stock might remain and it may see lower levels till Mahandai is fully commissioned," a Emkay Global report states.